SERVICES for almost 12,000 patients in Gwent who suffer a chronic, incurable lung disease will be modified to make them more consistent, and to reduce hospital admissions. Under Gwent’s five old Local…
Category: News
New F.D.A.: Transparence and Flexibility
During the Bush administration, the Food and Drug Administration was mostly a place of black-and-white decisions. Drugs were approved for sale or they were not, and the agency’s staff was expected to…
Promising New Therapy For Drug-Resistant Hypertension Presented At Interventional Cardiology Meeting In Washington, D.C.
Preclinical data of a novel therapy designed to treat drug-resistant hypertension (high blood pressure) was presented Tuesday, September 21st, at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 Conference in Washington, DC, by Christopher…
Potentially Avoidable Hospitalizations High Among Patients Eligible For Medicare And Medicaid
Americans who were eligible for coverage under both Medicare and Medicaid in 2008 were hospitalized for bed sores, asthma and diabetes at more than twice the rate of other Medicare beneficiaries, according…
Drug Sales In The Leukemia Market Will Be Driven By Therapies From Novartis, Bristol-Myers Squibb, Biogen Idec, Roche And Cephalon
Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that growth in the leukemia market will be driven mostly by chronic myelogenous leukemia (CML)…
Portable Laser Devices To Improve Disease Diagnosis
Portable devices that use a laser beam to probe bones, teeth, and other parts of the body for early signs of diseases like osteoporosis and tooth decay may seem like something out…
Legislation to help speed research for cystic fibrosis and other rare diseases
Today the U.S. House of Representatives passed the “Improving Access to Clinical Trials Act” (I-ACT), in a victory for the Cystic Fibrosis Foundation, its advocates and 120 other health advocacy organizations. The…
UC San Diego receives grant to study hypoxia susceptibility
Gabriel G. Haddad, MD, chair of the Department of Pediatrics at the University of California, San Diego School of Medicine and Physician-in-Chief at Rady Children’s Hospital-San Diego has received a $10 million…
Asthma linked to seven genetic variants
In a new study seven genes linked to asthma have been discovered. For the research genetic variations of 10,365 people with asthma and 16,110 people without the condition was studied. The variants…
NeoStem signs merger agreement to acquire Progenitor Cell Therapy
NeoStem, Inc. (NYSE Amex: NBS) an international biopharmaceutical company with operations in the U.S. and China and Progenitor Cell Therapy, LLC a privately held cell therapy company that serves the cell therapy…
CAP meeting to highlight medical diagnostic procedures
New science in cancer, genetic testing, molecular diagnostics, medical ethics, and gender-based disorders will be featured topics when nearly 1,200 pathologists gather at the Hyatt Regency Chicago on September 26 – 29…
A PILL FOR YOUTH
An anti-ageing drug could be on sale over the counter in just two years, a leading scientist said yesterday. It could add decades to lifespans and tests on thousands of human volunteers…
New superbug that is spread by farm animals
Superbug versions of common food poisoning bacteria have been found in farm animals across Britain, government scientists warn. The new and potentially deadlier strains of E.coli and salmonella are spreading in cattle…
FDA Approves First Oral Drug To Reduce MS Relapses
The U.S. Food and Drug Administration has approved Gilenya capsules (fingolimod) to reduce relapses and delay disability progression in patients with relapsing forms of multiple sclerosis (MS). “Gilenya is the first oral…
Rexahn Pharmaceuticals Announces Publication Of Study On Neuroprotective Effects Of Clavulanic Acid
Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, announced the publication of a research article in Drug Development…